Semnur Pharmaceuticals, Inc.
SEC CIK 1913577 · SMNR · last insider filing 2026-06-26
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Navani Annu | Director | filed 2025 - 2025 |
| Shah Jaisim | Director · See Remarks | filed 2025 - 2025 |
| Ji Henry | Director · Executive Chairperson | filed 2025 - 2025 |
| Wu Yue Alexander | Director | filed 2025 - 2025 |
| Followwill Dorman | Director | filed 2025 - 2025 |
| Chun Jay | Director | filed 2025 - 2025 |
| Chang Huifeng | Director | filed 2022 - 2022 |
| Vassily Kevin | Director | filed 2022 - 2022 |
| Huang Lei | Director · Chief Executive Officer | filed 2022 - 2022 |
| Mao Jim | Director | filed 2022 - 2022 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Ma Stephen Hoi | See Remarks | filed 2025 - 2025 |
| Sun You | Chief Financial Officer | filed 2022 - 2022 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.